Zhong Junhui, Li Nan, Chen Junxi, Liu Jufen, Li Zhiwen, Wang Jiamei, Liu Xiaohong
Institute of Reproductive and Child Health/National Health Commission Key Laboratory of Reproductive Health, School of Public Health, Peking University, Beijing, 100191, China.
Department of Epidemiology and Biostatistics, School of Public Health, Peking University, Beijing, 100191, China.
Nutr Metab (Lond). 2025 Jun 18;22(1):62. doi: 10.1186/s12986-025-00944-x.
To evaluate the efficacy of Multiple Micronutrient (MMN) Supplements during pregnancy in reducing the risk of anemia among pregnant women.
A retrospective cohort study was conducted with the supplement of Folic Acid (FA) only and FA plus MMN groups. Data was collected through questionnaires during the first prenatal visit. Hemoglobin levels were extracted from the Laboratory Information System. A total of 4,239 pregnant women who were admitted to Beijing Haidian Maternal & Child Health Hospital between May 2017 and November 2020 was evaluated. Chi-square tests and log-binomial regression were conducted to evaluate the relative risks (RRs) of two groups on the reduction of anemia during pregnancy.
The supplement of MMN was found to significantly decrease the risk of anemia in the later stages of pregnancy. Focusing on the third trimester specifically, the crude RR and adjusted RR were 0.891 and 0.844 respectively. In the second and third trimester of pregnancy, a sufficient monthly intake frequency of MMN(≥ 24 pills) is associated with a lower relative risk of anemia, with a value of 0.897 and 0.809 compared to the group supplement FA only.
The supplement of MMN has been correlated with a reduced risk of anemia in the second and third trimesters of pregnancy. But the efficacy was limited in the first trimester. Frequent and early initiation of supplementation with FA and MMN pills is associated with a more significant reduction in the risk of anemia compare to group supplement of FA only.
评估孕期补充多种微量营养素(MMN)对降低孕妇贫血风险的疗效。
进行一项回顾性队列研究,分为仅补充叶酸(FA)组和补充FA加MMN组。在首次产前检查时通过问卷调查收集数据。从实验室信息系统中提取血红蛋白水平。对2017年5月至2020年11月期间在北京海淀妇幼保健院住院的4239名孕妇进行了评估。采用卡方检验和对数二项回归分析来评估两组在孕期降低贫血风险方面的相对风险(RRs)。
发现补充MMN可显著降低妊娠后期的贫血风险。具体关注孕晚期,粗RR和调整后的RR分别为0.891和0.844。在妊娠的第二和第三个月,MMN的每月充足摄入频率(≥24片)与较低的贫血相对风险相关,与仅补充FA的组相比,该值分别为0.897和0.809。
补充MMN与妊娠第二和第三个月贫血风险降低相关。但在孕早期疗效有限。与仅补充FA的组相比,频繁且早期开始补充FA和MMN片与更显著降低贫血风险相关。